Zobrazeno 1 - 10
of 191
pro vyhledávání: '"E. van der Laan"'
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286429 (2023)
Every shelter dog is faced with the challenge to adapt to a kennel environment. To monitor the welfare of individual shelter dogs, evaluating behavioural and physiological parameters, potentially useful as indicators for adaptability of individual do
Externí odkaz:
https://doaj.org/article/89cb674134744852bacf2b4ce2d87d5f
Autor:
Louvina E. van der Laan, Anthony J. Garcia-Prats, H. Simon Schaaf, Jana L. Winckler, Heather Draper, Jennifer Norman, Lubbe Wiesner, Helen McIlleron, Paolo Denti, Anneke C. Hesseling
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Given the high prevalence of multidrug-resistant (MDR)-TB in high HIV burden settings, it is important to identify potential drug-drug interactions between MDR-TB treatment and widely used nucleoside reverse transcriptase inhibitors (NRTIs) in HIV-po
Externí odkaz:
https://doaj.org/article/0efbb15ebb8e4f389d9763f01fa80e8a
Autor:
Elisabeth M. W. Kooi, Michelle E. van der Laan, Ryan E. Accord, Marcus T. R. Roofthooft, Marcel J. Aries, Jan Willem J. Elting
Publikováno v:
Frontiers in Pediatrics, Vol 8 (2020)
Objective: During ligation of the ductus arteriosus, cerebrovascular autoregulation (CAR) may deteriorate. It is unknown whether different surgical approaches affect changes in CAR differently. The objective of this study was to compare the potential
Externí odkaz:
https://doaj.org/article/9c57751fd82c42b39ab4fd4c799f1a24
Autor:
Staci L. Sudenga, B. Nelson Torres, Matthys H. Botha, Michele Zeier, Martha E. Abrahamsen, Richard H. Glashoff, Susan Engelbrecht, Maarten F. Schim Van der Loeff, Louvina E. Van der Laan, Siegfried Kipping, Douglas Taylor, Anna R. Giuliano
Publikováno v:
Papillomavirus Research, Vol 3, Iss , Pp 50-56 (2017)
Background: HPV antibodies are a marker of past exposure to the virus. Our objective was to assess HPV serostatus pre- and post-vaccination among HIV-negative women. Methods: Women aged 16â24 years old were randomized in a placebo controlled trial u
Externí odkaz:
https://doaj.org/article/aae693d382134c899706bfad3397616f
Autor:
Anneke C. Hesseling, Barend Fourie, Jana Winckler, H. Simon Schaaf, Anthony J Garcia-Prats, James C. Nielsen, Belén P. Solans, Stephanie Thee, Lubbe Wiesner, Louvina E van der Laan, Radojka M. Savic, Heather R. Draper, Kendra K. Radtke
Publikováno v:
Clin Infect Dis
Background Moxifloxacin is a recommended drug for rifampin-resistant tuberculosis (RR-TB) treatment, but there is limited pediatric pharmacokinetic and safety data, especially in young children. We characterize moxifloxacin population pharmacokinetic
Autor:
Louvina E. van der Laan, Anthony J. Garcia-Prats, H. Simon Schaaf, Maxwell Chirehwa, Jana L. Winckler, Jun Mao, Heather R. Draper, Lubbe Wiesner, Jennifer Norman, Helen McIlleron, Peter R. Donald, Anneke C. Hesseling, Paolo Denti
Publikováno v:
Antimicrob Agents Chemother
Treatment options for children with Rifampicin-resistant tuberculosis (RR-TB) remain limited, and para-aminosalicylic acid (PAS) is still a relevant component of treatment regimens. Prevention of resistance to companion drugs by PAS is dose related,
Autor:
Trijntje E Schat, Maarten Schurink, Michelle E van der Laan, Jan B F Hulscher, Christian V Hulzebos, Arend F Bos, Elisabeth M W Kooi
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0154710 (2016)
OBJECTIVES:To investigate whether cerebral, liver, and infraumbilical regional tissue oxygen saturation (rSO2) and fractional tissue oxygen extraction (FTOE) could be used to diagnose necrotizing enterocolitis (NEC) and complicated NEC (Bell's stage
Externí odkaz:
https://doaj.org/article/be4e258680d24b36b4df61d92695d885
Autor:
Lubbe Wiesner, Jana Winckler, Roeland E Wasmann, Annelies Van Rie, Heather J. Zar, Elin M. Svensson, Louvina E. van der Laan, Helena Rabie, Helen McIlleron, Anneke C. Hesseling, Paolo Denti, Adrie Bekker, Carmen Gonzalez-Martinez, Gerry Davies
Publikováno v:
Clin Infect Dis
Clinical Infectious Diseases, 75, 141-151
CLINICAL INFECTIOUS DISEASES
Clinical Infectious Diseases, 75, 1, pp. 141-151
Clinical infectious diseases
Clinical Infectious Diseases, 75, 141-151
CLINICAL INFECTIOUS DISEASES
Clinical Infectious Diseases, 75, 1, pp. 141-151
Clinical infectious diseases
Background In 2010, the World Health Organization (WHO) revised dosing guidelines for treatment of childhood tuberculosis. Our aim was to investigate first-line antituberculosis drug exposures under these guidelines, explore dose optimization using t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fa0853f3cbea950b899b3dda6d7bea
https://doi.org/10.1093/cid/ciab908
https://doi.org/10.1093/cid/ciab908
Autor:
Kendra K. Radtke, Elin M. Svensson, Louvina E. van der Laan, Anneke C. Hesseling, Radojka M. Savic, Anthony J. Garcia-Prats
Publikováno v:
Expert Review of Clinical Pharmacology, 15, 2, pp. 161-174
Expert Review of Clinical Pharmacology, 15, 161-174
Expert Review of Clinical Pharmacology, 15, 161-174
Item does not contain fulltext INTRODUCTION: Despite its longstanding role in tuberculosis (TB) treatment, there continues to be emerging rifampicin research that has important implications for pediatric TB treatment and outstanding questions about i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1abdc88fc9825a51e2757a2245da0f9
https://doi.org/10.1080/17512433.2022.2053110
https://doi.org/10.1080/17512433.2022.2053110
Autor:
Anthony J. Garcia-Prats, Anneke C. Hesseling, Jana Winckler, L E van der Laan, Helen McIlleron, Heather Draper, Lubbe Wiesner, Jennifer Norman, H S Schaaf, Peter R. Donald
Publikováno v:
Int J Tuberc Lung Dis
BACKGROUND: High-dose isoniazid (INHH) (15–20 mg/kg/day) could be administered to overcome low-level INH resistance, but pharmacokinetic data are sparse.METHODS: This observational study included South African children (H as preventive therapy, or